John Burn talking at ECCO15-ESMO34 in Berlin about his international study showing that aspirin prevented the development of Hereditary Non-Polyposis Colon Cancer in people genetically at risk for the disease.

John Burn talking at ECCO15-ESMO34 in Berlin about his international study showing that aspirin prevented the development of Hereditary Non-Polyposis Colon Cancer in people genetically at risk for the disease.

John Burn talking at ECCO15-ESMO34 in Berlin about his international study showing that aspirin prevented the development of Hereditary Non-Polyposis Colon Cancer in people genetically at risk for the disease.

Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!

Share Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

Sign up to save your podcasts

Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

More shows like Oncology Times - OncTimes Talk

Breast Cancer Trials